换一批Oral cyclophosphamide therapy for patients with residual or relapsed indolent-type lymphoma after initial treatment for aggressive lymphomas. A sub-group of patients with apparent transformed indolent lymphoma.
第一作者：
R,Riccioni
第一单位：
Haematology Division, Department of Oncology, Transplant and Advanced Technologies, University of Pisa-Ospedale Santa Chiara Via Roma 56100 Pisa, Italy.
作者：
医学主题词
投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);环磷酰胺(Cyclophosphamide);女(雌)性(Female);人类(Humans);淋巴瘤(Lymphoma);男(雄)性(Male);中年人(Middle Aged);复发(Recurrence);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1080/1042819021000006448
PMID
12685835
发布时间
2019-01-16
- 浏览21
Leukemia & lymphoma
1803-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
